Raymond James Financial Services Advisors’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-97
Closed -$7.43K 3317
2023
Q2
$7.43K Hold
97
﹤0.01% 3204
2023
Q1
$9.18K Hold
97
﹤0.01% 3217
2022
Q4
$9.47K Sell
97
-38
-28% -$3.71K ﹤0.01% 3171
2022
Q3
$35K Sell
135
-1
-0.7% -$259 ﹤0.01% 3106
2022
Q2
$25K Buy
136
+44
+48% +$8.09K ﹤0.01% 3121
2022
Q1
$9K Sell
92
-47
-34% -$4.6K ﹤0.01% 3242
2021
Q4
$23K Sell
139
-24
-15% -$3.97K ﹤0.01% 3201
2021
Q3
$44K Buy
163
+31
+23% +$8.37K ﹤0.01% 3177
2021
Q2
$52K Sell
132
-30
-19% -$11.8K ﹤0.01% 3179
2021
Q1
$87K Buy
162
+41
+34% +$22K ﹤0.01% 3043
2020
Q4
$46K Sell
121
-2
-2% -$760 ﹤0.01% 2901
2020
Q3
$46K Sell
123
-9
-7% -$3.37K ﹤0.01% 2754
2020
Q2
$65K Hold
132
﹤0.01% 2674
2020
Q1
$49K Sell
132
-30
-19% -$11.1K ﹤0.01% 2303
2019
Q4
$115K Buy
+162
New +$115K ﹤0.01% 2681
2019
Q3
Sell
-358
Closed -$313K 2868
2019
Q2
$313K Buy
358
+64
+22% +$56K ﹤0.01% 2242
2019
Q1
$170K Sell
294
-19
-6% -$11K ﹤0.01% 2533
2018
Q4
$88K Buy
+313
New +$88K ﹤0.01% 2410
2018
Q3
Sell
-941
Closed -$426K 2845
2018
Q2
$426K Sell
941
-78
-8% -$35.3K ﹤0.01% 1982
2018
Q1
$599K Buy
1,019
+23
+2% +$13.5K ﹤0.01% 1609
2017
Q4
$618K Buy
996
+76
+8% +$47.2K ﹤0.01% 1586
2017
Q3
$847K Buy
920
+42
+5% +$38.7K 0.01% 1415
2017
Q2
$819K Sell
878
-18
-2% -$16.8K 0.01% 1389
2017
Q1
$852K Sell
896
-11
-1% -$10.5K 0.01% 1276
2016
Q4
$728K Sell
907
-206
-19% -$165K 0.01% 1297
2016
Q3
$940K Sell
1,113
-165
-13% -$139K 0.01% 1118
2016
Q2
$1.05M Sell
1,278
-7
-0.5% -$5.76K 0.01% 1009
2016
Q1
$1.43M Buy
1,285
+49
+4% +$54.5K 0.02% 757
2015
Q4
$1.54M Buy
1,236
+471
+62% +$587K 0.02% 746
2015
Q3
$1.03M Buy
+765
New +$1.03M 0.02% 760